Jun 24 |
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
Jun 24 |
Tech sector growth, EU considers fining Apple: Morning Brief
|
Jun 24 |
Top Stock Movers Now: Affirm, Nvidia, ResMed, and More
|
Jun 24 |
ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential
|
Jun 24 |
Lilly Declares Third-Quarter 2024 Dividend
|
Jun 24 |
Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling
|
Jun 24 |
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
Jun 24 |
What Makes Eli Lilly & Company (LLY) a Hot Healthcare Stock Right Now?
|
Jun 24 |
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
|
Jun 24 |
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|